Artificial intelligence-based pathology as a biomarker of sensitivity to atezolizumab-bevacizumab in patients with hepatocellular carcinoma: a multicentre retrospective study
Zeng et al., Lancet Oncology, 2023
We show in this paper that Artificial Intelligence-based pathology is able to predict clinical outcomes in patients with advanced hepatocellular carcinoma treated by atezolizumab/bevacizumab​​
Artificial intelligence in liver cancer - new tools for research and patient management
Calderaro et al., Nat Rev Gastroenterol Hepatol, 2024
​
This review discusses the main applications of AI for liver cancer.​​
Deep learning-based phenotyping reclassifies combined hepatocellular-cholangiocarcinoma
Calderaro et al., Nature Communications, 2023 ​
This manuscript shows that Artificial Intellligence can reclassify combined HCC-CCA as conventional HCC or cholangiocarcinoma, and that this reclassification has clinical and molecular relevance